r acting with intent to defraud
and mislead, resulting in drugs being misbranded while held for sale after
shipment in interstate commerce, is three years in prison, a $250,000 fine,
one year supervised release, and $100 mandatory special assessment.
However, any sentence following conviction would be imposed by the court
after consideration of the U.S. Sentencing Guidelines and the federal
statute governing the imposition of a sentence. Harkonen is scheduled to be
arraigned on Friday, March 28, 2008, at 9:30 a.m. before the Hon.
Magistrate Judge Joseph C. Spero.
"Pharmaceutical executives who promote drugs using false and misleading
information should not be allowed to hide behind a corporate shield," said
Kim Rice, Special Agent in Charge of FDA's Office of Criminal
Investigations, Washington Field Office. "Pharmaceutical companies do not
run themselves, and those who engage in criminal conduct will be held
"We have an obligation to pursue and bring to justice those who prey on
the vulnerable and place profits before public health," said FBI Special
Agent in Charge Charlene B. Thornton. "This four-year investigation
reflects the seriousness with which the FBI takes violations of the law by
those entrusted to safeguard the health of the public."
"The results of this criminal investigation show our commitment to
protect the Veteran Administration's healthcare system from deceptive and
fraudulent practices by pharmaceutical companies," said Special Agent in
Charge Douglas J. Carver of the U.S. Department of Veterans Affairs, Office
of Inspector General. These charges are the result of a multi-year
investigation by the Federal Bureau of Investigation; the Food and Drug
Administration's Office of Criminal Investigations; the Department of
Veterans' Affairs' Office of Investigations; and the Office of Personnel
Management's Office of Investigations.
This case is being prosecuted by Assistant U.S. Attorney Ioan
Page: 1 2 3 4 Related medicine news :1
|SOURCE U.S. Department of Justice|
Copyright©2008 PR Newswire.
All rights reserved
. Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post2
. Former Federal Reserve Chairman Paul Volcker To Join Board of Directors of Still River Systems3
. Thomas Farina, Former Pharmaceutical Company District Manager, Charged With Obstruction of Justice4
. Former Blue Cross/Blue Shield Account Manager Sentenced for Health Care Fraud Scheme, Tax Evasion5
. Lilly and Partners In Health, Brigham and Womens Hospital Team Up to Fight MDR-TB in Former Soviet Republics6
. Former Biolase CEO & EVP Launch Technology4Medicine7
. Nyer Medical Group Completes Acquisition of Minority Interest in Pharmacy Chain Subsidiary; Former Minority Shareholders Invest in Nyer Medical Group and Sign 3-Year Employment Agreements8
. OrthoSynetics(TM) Applauds SEC Suit Against Former Company Management9
. Local VA Performers Hold February 15 Benefit to Reduce $10,000 in Medical Bills for Former VCU Student Kellie Brown10
. Herley Industries Announces the Passing of Its Former President11
. Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members